Nuquin Hp (Stratus Pharmaceuticals)


Welcome to the PulseAid listing for the Nuquin Hp drug offered from Stratus Pharmaceuticals. This Depigmenting Activity [PE],Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Stratus Pharmaceuticals
NON-PROPRIETARY NAME: Hydroquinone, Padimate O, and Dioxybenzone
SUBSTANCE NAME: HYDROQUINONE; PADIMATE O; DIOXYBENZONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Depigmenting Activity [PE],Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA]
ROUTE: TOPICAL
DOSAGE FORM: GEL
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 1999-09-14
END MARKETING DATE: 0000-00-00


Nuquin Hp HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNuquin Hp from Stratus Pharmaceuticals
LABELER NAME: Stratus Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 40; 50; 30(mg/g; mg/g; mg/g)
START MARKETING DATE: 1999-09-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 58980-475_6685425c-79a1-423e-8302-5630e1811d32
PRODUCT NDC: 58980-475
APPLICATION NUMBER:

Other HYDROQUINONE; PADIMATE O; DIOXYBENZONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Stratus PharmaceuticalsNuquin Hp